Blood Reagents Antitrust Class Action Lawsuit

A Class has been certified in a class action lawsuit that accuses Ortho-Clinical Diagnostics Inc. and Immucor Inc. of conspiring to fix the prices of traditional blood reagents in violation of federal antitrust law. If you purchased traditional blood reagents from Ortho-Clinical or Immucor between Nov. 4, 2000 and Oct. 19, 2015, your rights may be affected by this class action lawsuit.

Blood reagents are products that are able to test, detect, match, screen, diagnose and/or identify certain properties of human blood. Traditional blood reagents are primarily used to manually test blood in test tubes.

According to the antitrust class action lawsuit, the alleged conspiracy between Immucor and Ortho-Clinical caused individuals and entities to pay artificially inflated prices for traditional blood reagents.

The defendants deny any wrongdoing and maintain that their conduct was not unlawful.

In 2012, Immucor agreed to settle the antitrust class action lawsuit. The $22 million Immucor class action settlement was given final approval and Immucor was dismissed as a defendant from the litigation in September 2012.

The antitrust claims against Ortho-Clinical are still pending. A trial against Ortho-Clinical has not yet been scheduled.

To exclude yourself from the Ortho-Clinical class action settlement, you must submit an exclusion request to the Settlement Administrator, postmarked no later than April 6, 2016.

Who’s Eligible

You are a Class Member in this antitrust litigation if you purchased traditional blood reagents directly from Ortho-Clinical Diagnostics Inc. and/or Immucor Inc. between Nov. 4, 2000 and Oct. 19, 2015.

Potential Award

N/A. There is currently no money available to Class Members.

The Immucor class action settlement was given final approval in 2012, but a plan of distribution has not yet been determined.

The antitrust class action lawsuit against Ortho-Clinical is ongoing.

Proof of Purchase

N/A

FAQs

FREQUENTLY ASKED QUESTIONS »

Claim Form Deadline

N/A. There is currently no money available to Class Members, but there may be money available in the future. Keep checking TopClassActions.com or sign up for our free newsletter for the latest updates. You can also mark this article as a “Favorite” using your free Top Class Actions account to receive notifications when this article is updated.

Case Name

In re: Blood Reagents Antitrust Litigation, Case No. 2:09-md-02081-JD, in the U.S. District Court for the Eastern District of Pennsylvania

Final Hearing

N/A. The litigation against Ortho-Clinical is still ongoing.

The Immucor class action settlement received final approval on Sept. 6, 2012. However, a plan of distribution to eligible Class Members has not yet been approved. There is currently no  money available to Class Members, but there may be in the future.

Settlement Website

www.BloodReagentsAntitrustLitigation.com

Claims Administrator

Blood Reagents Antitrust Litigation Administrator
c/o Kurtzman Carson Consultants LLC
P.O. Box 43058
Providence, RI 02940-3058
1-855-231-9423

Class Counsel

SPECTOR ROSEMAN KODROFF & WILLIS PC

Defense Counsel

Counsel for Immucor:
HUNTON & WILLIAMS LLP